Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system

BACKGROUND: Raloxifene, a second-generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women is administered orally in the form of a tablet. The absolute bioavailability of the drug is only 2% because of extensive hepatic first-pass metabolism. Lipid-...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakkar, Hetal, Nangesh, Jitesh, Parmar, Mayur, Patel, Divyakant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications Pvt Ltd 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178953/
https://www.ncbi.nlm.nih.gov/pubmed/21966167
http://dx.doi.org/10.4103/0975-7406.84463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178953/
https://www.ncbi.nlm.nih.gov/pubmed/21966167
http://dx.doi.org/10.4103/0975-7406.84463

Ejemplares similares